Table 3.
Top upstream regulators selected by Bayes-CRE in response to infliximab treatment in UC patients
Rank | Upstream regulator | Direction | Probability |
---|---|---|---|
1 | IFNG | Down | 1.00 |
2 | LPS | Down | 1.00 |
3 | TNF | Down | 0.99 |
4 | Retinoic acid | Down | 0.92 |
5 | SE LPS | Down | 0.89 |
6 | Poly rI:rC-RNA | Down | 0.86 |
7 | Decitabine | Down | 0.82 |
8 | Allergens | Down | 0.77 |
9 | IL1 | Down | 0.62 |